Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Charlton

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Hepatology|June 19, 2010
Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitisQuentin M Anstee, Danilo Concas, Hiromi Kudo, et al.
Critical Care (London, England)|September 11, 2009
VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsisPeter Weber, Ping Wang, Stephane Maddens, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistanceShouming Wang, Hamish Ryder, Ian Pretswell, et al.
The Biochemical Journal|May 2, 2003
Biochemical mechanism of action of a diketopiperazine inactivator of plasminogen activator inhibitor-1Anja P Einholm, Katrine E Pedersen, Troels Wind, et al.
Molecular Cancer Therapeutics|January 30, 2004
Biological characterization of MLN944: a potent DNA binding agentDarshan S Sappal, A Kathleen McClendon, James A Fleming, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 27, 2024
The feasibility of population screening for paroxysmal atrial fibrillation using hand-held electrocardiogram devicesJonathan Mant, Rakesh N Modi, Peter Charlton, et al.
Cancer Research|October 2, 2014
ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responsesRozenn Jossé, Scott E Martin, Rajarshi Guha, et al.
Science Translational Medicine|April 8, 2016
A "datathon" model to support cross-disciplinary collaborationJerôme Aboab, Leo Anthony Celi, Peter Charlton, et al.
Hepatology (Baltimore, Md.)|August 14, 2009
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitisRafal P Witek, W Carl Stone, F Gamze Karaca, et al.
Oncotarget|July 11, 2014
Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970Amy B Hall, Dave Newsome, Yuxin Wang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|June 19, 2010
Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitisQuentin M Anstee, Danilo Concas, Hiromi Kudo, et al.
Critical Care (London, England)|September 11, 2009
VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsisPeter Weber, Ping Wang, Stephane Maddens, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistanceShouming Wang, Hamish Ryder, Ian Pretswell, et al.
The Biochemical Journal|May 2, 2003
Biochemical mechanism of action of a diketopiperazine inactivator of plasminogen activator inhibitor-1Anja P Einholm, Katrine E Pedersen, Troels Wind, et al.
Molecular Cancer Therapeutics|January 30, 2004
Biological characterization of MLN944: a potent DNA binding agentDarshan S Sappal, A Kathleen McClendon, James A Fleming, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 27, 2024
The feasibility of population screening for paroxysmal atrial fibrillation using hand-held electrocardiogram devicesJonathan Mant, Rakesh N Modi, Peter Charlton, et al.
Cancer Research|October 2, 2014
ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responsesRozenn Jossé, Scott E Martin, Rajarshi Guha, et al.
Science Translational Medicine|April 8, 2016
A "datathon" model to support cross-disciplinary collaborationJerôme Aboab, Leo Anthony Celi, Peter Charlton, et al.
Hepatology (Baltimore, Md.)|August 14, 2009
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitisRafal P Witek, W Carl Stone, F Gamze Karaca, et al.
Oncotarget|July 11, 2014
Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970Amy B Hall, Dave Newsome, Yuxin Wang, et al.
Pageof 3